Emanuela Taioli Selected Research

isoleucylvaline

4/2009	Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC review.
9/2004	Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis.
5/2003	CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emanuela Taioli Research Topics

Disease

49	Neoplasms (Cancer) 01/2022 - 02/2002
31	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2002
23	Genetic Predisposition to Disease (Genetic Predisposition) 02/2020 - 08/2002
12	Breast Neoplasms (Breast Cancer) 11/2020 - 06/2004
12	Malignant Mesothelioma 02/2020 - 12/2005
9	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2010
8	Mesothelioma 01/2022 - 02/2015
7	Carcinogenesis 04/2013 - 05/2003
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 10/2013
5	Obesity 01/2022 - 07/2005
4	Infections 01/2021 - 11/2003
3	COVID-19 01/2022 - 01/2021
3	Neoplasm Metastasis (Metastasis) 02/2021 - 01/2018
3	Inflammation (Inflammations) 01/2019 - 05/2014
3	Urinary Bladder Neoplasms (Bladder Cancer) 11/2017 - 07/2002
3	Endometrial Neoplasms (Endometrial Cancer) 12/2008 - 05/2008
3	Thrombophilia 12/2003 - 05/2002
2	Hepatitis B 01/2022 - 01/2018
2	Asthma (Bronchial Asthma) 01/2022 - 01/2018
2	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 01/2019
2	Dementia (Dementias) 01/2021 - 01/2020
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2020 - 07/2019
2	Stomach Neoplasms (Stomach Cancer) 01/2019 - 03/2008
2	Myasthenia Gravis 01/2018 - 12/2016
2	Chronic Disease (Chronic Diseases) 09/2014 - 02/2013
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2013 - 02/2009
2	Squamous Cell Carcinoma of Head and Neck 11/2011 - 05/2010
2	Head and Neck Neoplasms (Head and Neck Cancer) 08/2011 - 12/2003
2	Pharyngeal Neoplasms 10/2009 - 06/2008
2	Adenocarcinoma of Lung 06/2009 - 05/2003
2	Chromosome Aberrations (Chromosome Abnormalities) 07/2007 - 11/2003
2	Poliomyelitis (Polio) 03/2006 - 01/2005
2	Chronic Kidney Failure (Chronic Renal Failure) 02/2004 - 03/2003
2	Venous Thromboembolism 12/2003 - 05/2002
1	Hypoxia (Hypoxemia) 01/2022
1	Human Influenza (Influenza) 01/2022
1	Hypertension (High Blood Pressure) 01/2022

Drug/Important Bio-Agent (IBA)

23	Biomarkers (Surrogate Marker)IBA 07/2021 - 09/2002
15	Environmental CarcinogensIBA 09/2011 - 08/2002
11	CarcinogensIBA 01/2019 - 02/2002
11	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2010 - 05/2003
8	AsbestosIBA 11/2020 - 12/2005
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2004
6	VaccinesIBA 01/2022 - 01/2005
6	DNA AdductsIBA 07/2007 - 03/2003
5	Estrogens (Estrogen)FDA Link 10/2019 - 09/2009
5	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 09/2007 - 03/2003
4	CotinineIBA 10/2020 - 11/2016
4	Hormones (Hormone)IBA 09/2014 - 08/2008
4	LeptinIBA 06/2013 - 07/2005
4	EnzymesIBA 01/2010 - 05/2003
3	Opioid Analgesics (Opioids)IBA 01/2021 - 11/2018
3	Estrogen ReceptorsIBA 11/2020 - 04/2013
3	Biological ProductsIBA 12/2012 - 02/2005
3	valylvaline (Val-Val)IBA 04/2009 - 05/2003
3	isoleucylvalineIBA 04/2009 - 05/2003
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 02/2009 - 05/2003
3	SmokeIBA 09/2007 - 07/2002
3	glutathione S-transferase M1IBA 05/2003 - 07/2002
2	Immune Checkpoint InhibitorsIBA 11/2022 - 08/2020
2	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2022 - 01/2018
2	Oxygen (Dioxygen)IBA 01/2022 - 11/2018
2	AnticoagulantsIBA 07/2021 - 01/2021
2	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2021 - 02/2009
2	HerbicidesIBA 12/2020 - 07/2019
2	Glyphosate (Roundup)IBA 12/2020 - 07/2019
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2018
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 05/2014
2	C-Reactive ProteinIBA 01/2018 - 08/2015
2	Pharmaceutical PreparationsIBA 01/2018 - 02/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2013 - 05/2008
2	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 05/2013 - 01/2010
2	Cytochrome P-450 CYP3AIBA 05/2013 - 01/2010
2	Oral ContraceptivesIBA 11/2011 - 12/2003
2	ParaffinIBA 04/2011 - 02/2004
2	Glutathione Transferase (Glutathione S-Transferase)IBA 10/2010 - 06/2007
2	valylleucineIBA 02/2009 - 01/2007
2	Codon (Codons)IBA 02/2009 - 09/2004
2	Leptin ReceptorsIBA 11/2008 - 07/2005
2	Tumor Biomarkers (Tumor Markers)IBA 08/2008 - 05/2008
2	CytokinesIBA 05/2008 - 02/2002
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 03/2008 - 07/2003
2	CreatinineIBA 02/2004 - 03/2003
2	Prothrombin (Factor II)IBA 07/2003 - 05/2002
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	hydrogen sulfite (bisulfite)IBA 01/2022

Therapy/Procedure

14	Therapeutics 11/2022 - 04/2008
5	Radiotherapy 11/2020 - 01/2018
4	Pneumonectomy (Lung Volume Reduction) 12/2018 - 02/2015
4	Thoracotomy 01/2018 - 10/2013
3	Drug Therapy (Chemotherapy) 01/2021 - 12/2008
2	Immunotherapy 01/2022 - 11/2018
2	Castration 02/2021 - 01/2018
2	Aftercare (After-Treatment) 01/2019 - 11/2018
2	Length of Stay 11/2018 - 11/2017
2	Thymectomy 01/2018 - 12/2016
2	Ovariectomy (Oophorectomy) 11/2011 - 06/2004
2	Organ Transplantation 04/2008 - 02/2004
2	Kidney Transplantation 02/2004 - 11/2003